MedCity News
JUNE 30, 2024
By being aware of the latest schemes, health plan leaders can ensure their members have appropriate access to care while preventing bad actors from exploiting telehealth policies established during the pandemic. The post Mental Health Fraud Schemes: How to Protect Your Plan appeared first on MedCity News.
pharmaphorum
JUNE 30, 2024
After FDA rejection last year, ARS Pharma closes on EU approval for intranasal epinephrine product for anaphylaxis
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JUNE 30, 2024
Health plans must take a consistent, thoughtful approach to sustaining their business by managing costs without compromising member access to quality healthcare. The post Four Strategies Medicare Advantage Plans Can Implement to Mitigate Financial Pressures appeared first on MedCity News.
Pharmacy Times
JUNE 30, 2024
Pharmacists can also play a role in SDOH by replacing drug delivery with something else, such as food or transportation delivery, according to speakers at the ATOPP conference.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
MedCity News
JUNE 30, 2024
CMS recently announced that it is recalculating Medicare Advantage Star Ratings. It comes after two lawsuits on the issue. The post Why Insurers Beat CMS In the MA Star Ratings Battle appeared first on MedCity News.
MedCity News
JUNE 30, 2024
AbbVie has acquired Celsius Therapeutics, a startup whose lead program is in early clinical development for inflammatory bowel disease. It’s the latest in a series of AbbVie business deals that broaden the pharma company’s scope in the gastrointestinal condition. The post AbbVie Expands IBD Drug Pipeline Again With $250M Celsius Therapeutics Acquisition appeared first on MedCity News.
Expert insights. Personalized for you.
113 
Let's personalize your content